Evolus Inc
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels.… Read more
Evolus Inc (EOLS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.510x
Based on the latest financial reports, Evolus Inc (EOLS) has a cash flow conversion efficiency ratio of 0.510x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-14.67 Million) by net assets ($-28.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evolus Inc - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Evolus Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Evolus Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evolus Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hextar Global Bhd
KLSE:5151
|
0.160x |
|
Borussia Dortmund GmbH & Co KGaA
XETRA:BVB
|
-0.040x |
|
Fujian Oriental Silver Star Investment Co Ltd
SHG:600753
|
-0.569x |
|
G-Tech Optoelectronics Corp
TW:3149
|
-0.037x |
|
PropertyGuru Group Ltd
NYSE:PGRU
|
0.026x |
|
Sveafastigheter
ST:SVEAF
|
0.017x |
|
Beneteau SA
LSE:0K8N
|
0.016x |
|
Text S.A.
PINK:LCHTF
|
0.302x |
Annual Cash Flow Conversion Efficiency for Evolus Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Evolus Inc from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $5.52 Million | $-18.00 Million | -3.260x | -298.29% |
| 2023-12-31 | $-20.69 Million | $-34.01 Million | 1.644x | +135.81% |
| 2022-12-31 | $18.50 Million | $-84.91 Million | -4.590x | -1025.61% |
| 2021-12-31 | $81.88 Million | $-33.39 Million | -0.408x | -151.41% |
| 2020-12-31 | $-72.96 Million | $-57.87 Million | 0.793x | +167.49% |
| 2019-12-31 | $79.46 Million | $-93.38 Million | -1.175x | -286.39% |
| 2018-12-31 | $84.38 Million | $-25.67 Million | -0.304x | -276.28% |
| 2017-12-31 | $-75.54 Million | $-13.04 Million | 0.173x | -90.76% |
| 2016-12-31 | $-7.11 Million | $-13.27 Million | 1.867x | +161.59% |
| 2015-12-31 | $12.00 Million | $-36.38 Million | -3.031x | -- |